While these medications offer unprecedented health benefits, they come with challenges like cost, non-adherence and lack of ...

US pharmaceutical company Eli Lilly launched its once-a-week weight loss injection Mounjaro in ... The real market challenge could emerge by next year when India could see generic copies of ...

Southwest Airlines is the largest carrier in the US by passenger volume. It has stuck to its strategy of streamlining airline operations to maintain lower unit costs than its full-service rivals, ...

Overcoming Weight Loss Plateaus with Keto + ACV Gummies When it comes to achieving long-term weight loss success, plateaus are a common obstacle that many dieters face. To overcome this challenge ...

Commercial weight loss programs have long been a popular option for those looking to shed a few pounds or manage their weight, but recently, they’ve evolved dramatically—parti ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

A $5,000 weight-loss challenge between me and my wife was the push I needed to move more and eat better.

Last week, Pfizer announced that it would no longer develop danuglipron, a daily GLP-1 weight-loss drug which investors were excited about as a potential blockbuster for the company. This wasn't ...

After years of falling Covid treatment sales, lukewarm drug launches and a fizzled out weight-loss play, Pfizer is focusing on cost-cutting and reinvesting in new drug research in hopes that it can ...

Psychologically, the plateau is a huge challenge after the high of consistent weight loss in the first several months, but the scientists say this period is not an obstacle but an opportunity.

Pfizer has encountered many setbacks in its quest to launch a medicine that could rival Wegovy and Zepbound. One of its ...

Pfizer is halting development of its experimental weight-loss pill, as the booming obesity drug market remains out of reach for the drug giant. The company said Monday the stoppage comes after it ...